siRNA and PCSK9 Therapies in Modern Lipid Care – Dr. Amber Johnson

17 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
In this segment, Dr. Amber Johnson explores how siRNA cholesterol therapy and PCSK9 inhibitors are reshaping modern cholesterol control therapy, especially for patients who cannot tolerate statins or are not reaching targets with traditional treatment. She explains where inclisiran fits within non statin lipid therapy, how it differs from statins in dosing and mechanism, and why it has become an important option in contemporary lipid management in cardiology.

The discussion also moves beyond LDL alone to address triglycerides and cholesterol, remnant cholesterol, and their role in residual cardiovascular risk. Dr. Johnson breaks down how abnormalities in ldl cholesterol, hdl cholesterol, and other lipoprotein particles can signal broader metabolic risk, including hypertriglyceridemia and its connection to pancreatitis risk, chronic pancreatitis, and overall pancreas health.

What You’ll Learn in This Segment
▶ How inclisiran works in siRNA cholesterol therapy
▶ When inclisiran vs statin becomes a clinical decision
▶ The role of PCSK9-based low cholesterol therapy in high-risk care
▶ How triglycerides, remnant cholesterol, and LDL interact
▶ Why severe triglyceride elevation raises pancreatitis risk
▶ Where omega 3 fatty acids and omega 3 therapy may fit

Dr. Johnson emphasizes that effective lipid management requires looking at the full lipid profile—not just LDL—and tailoring therapy to patient tolerance, access, and long-term risk. By combining advanced therapies with targeted lifestyle and adjunct treatments, cardiology teams can better reduce cardiovascular and metabolic complications linked to cholesterol and triglyceride disorders.

#cholesterol #lipidmanagement #cardiology #sirnatherapy #pcsk9 #inclisiran #triglycerides #hypertriglyceridemia #pancreatitis #hearthealth #ldlcholesterol #hdlcholesterol #nonstatintherapy #moderncardiology #mdnewsline
Categoria
Cardiology
Commenta per primo questo video.

Prossimo